ArticleProteins2026
AlphaFold3 at CASP16.
Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Hierarchical breakdown of RNA structure prediction in CASP16: from reliable local helices to speculative multimer assembly.Bioinformatics (Oxford, England) · 2026Article
- MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome.Nucleic acids research · 2026Article
- Reimagining computational macromolecular modeling: AI-driven approaches.Biophysical journal · 2026Review
- A simple probabilistic AlphaFold interaction score.Protein science : a publication of the Protein Society · 2026Article
- Stoic: fast and accurate protein stoichiometry prediction.Bioinformatics (Oxford, England) · 2026Article
- Target discovery and drug design in the era of artificial intelligence.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026Review
- Reciprocal best matching: a new pipeline for scoring models with unknown stoichiometry in CASP experiments.BMC bioinformatics · 2026Article
- Unavailability of experimental 3D structural data on protein folding dynamics and necessity for a new generation of structure prediction methods in this context.Bioinformatics (Oxford, England) · 2026Article
- Progress and Bottlenecks for Deep Learning in Computational Structure Biology: CASP Round XVI.Proteins · 2026Article
- RNApedia: a database of structural protein-RNA interactions.Frontiers in bioinformatics · 2026Article
- Practical Outcomes From CASP16 for Users in Need of Biomolecular Structure Prediction.Proteins · 2026Review
- AlphaFold3 at CASP16.Proteins · 2026Article
- Beyond AlphaFold: Charting the Future of AI in Protein Structure Prediction.Current drug targets · 2026Article
- High-accuracy protein complex structure modeling based on sequence-derived structure complementarity.Nature communications · 2025Article
- Protocol for deriving distance restraints from AlphaFold for use in solution NMR structure determination.STAR protocols · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The CASP16 experiment provided the first opportunity to benchmark AlphaFold3. In contrast to AlphaFold2, AlphaFold3 can predict the structure of non-protein molecules. According to the benchmark presented by the developers, it is expected to perform slightly better than AlphaFold2 for proteins. In this study, we assess the performance of AlphaFold3 using both automatic server submissions (AF3-server) and manual predictions from the Elofsson group (Elofsson). All predictions were generated via the AlphaFold3 web server, with manual interventions applied to large targets and ligands. Compared to AlphaFold2-based methods, we found that AlphaFold3 performs slightly better for protein complexes. However, when massive sampling is applied to AlphaFold2, the difference disappears. It was also noted that, according to the official ranking from CASP, the AF3-server performs better than AlphaFold2 for easier targets, but not for harder targets. Furthermore, the performance of the AF3-server is comparable to the best methods when considering the top-ranked predictions, but slightly behind when examining the best among the five submitted models. Here, there exist targets where AF3-server, the top-ranked method, is worse than lower-ranked models, indicating that a venue for progress could be to develop better strategies for identifying the best out of the generated models. When using AF3-server to predict the stoichiometry of larger protein complexes, the accuracy is limited, especially for heteromeric targets. When analyzing the predictions including nucleic acids, it was found that, in general, the accuracy is relatively low. However, the AF3-server performance was not far behind that of the top-ranked method. In summary, AF3-server offers a user-friendly tool that provides predictions comparable to state-of-the-art methods in all categories of CASP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.